LAKIN Trademark

Trademark Overview


On Thursday, October 10, 2024, a trademark application was filed for LAKIN with the United States Patent and Trademark Office. The USPTO has given the LAKIN trademark a serial number of 98794930. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, April 16, 2025. This trademark is owned by Veritus Surgical Consulting Enterprises, LLC. The LAKIN trademark is filed in the Medical Instrument Products category with the following description:

Medical instrument, namely, hand held spacing tool used during orthopedic procedures on the foot to ensure proper bone alignment
lakin

General Information


Serial Number98794930
Word MarkLAKIN
Filing DateThursday, October 10, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, April 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical instrument, namely, hand held spacing tool used during orthopedic procedures on the foot to ensure proper bone alignment

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, October 10, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVeritus Surgical Consulting Enterprises, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCanyon Lake, TX 78133

Trademark Events


Event DateEvent Description
Thursday, October 10, 2024NEW APPLICATION ENTERED
Friday, April 11, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 14, 2025ASSIGNED TO EXAMINER
Wednesday, April 16, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 16, 2025NON-FINAL ACTION WRITTEN
Wednesday, April 16, 2025NON-FINAL ACTION E-MAILED